Scientists from the Siberian Branch of the Russian Academy of Sciences have found antibodies against SARS-CoV-2 that “neutralize” the SARS-CoV-2 coronavirus stronger than those used to treat former US President Donald Trump, RAS head Alexander Sergeev reported.
One of the directions of creating drugs against COVID-19 was the search for so-called neutralizing antibodies – molecules produced by immune system cells in response to the virus entering the body. Researchers are trying to combine them into drug “cocktails.
“Out of the entire large spectrum, three antibodies have now been identified that have a binding constant (with viral particles) greater than the corresponding values in the first two US drugs that have already been registered by Regeneron,” Sergeev said at a press conference at the site of the Russia Today news agency.
According to him, these antibodies “have very serious potential to be used to make drugs based on them.
An experimental drug by Regeneron last year treated former U.S. President Donald Trump. It consists of a mixture of monoclonal antibodies. One course will cost two thousand euros.
Earlier Sergeev said that soon the Ministry of Health will be given the results of tests of a molecule of therapeutic monoclonal antibody neutralizing SARS-CoV-2 coronavirus, created by the Institute of Bioorganic Chemistry RAS (Moscow), the Russian company “Pharmsintez” and international biopharmaceutical company HifiBio Therapeutics.